Similar articles for PMID: 18305012

Year	Number of Results
1997	1
1998	1
2003	2
2004	9
2005	9
2006	9
2007	18
2008	27
2009	26
2010	16
2011	14
2012	16
2013	17
2014	13
2015	9
2016	9
2017	7
2018	12
2019	10
2020	10
2021	8
2022	8
2023	2
2024	0

1

Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.

Le S, Gruner JA, Mathiasen JR, Marino MJ, Schaffhauser H. Le S, et al. J Pharmacol Exp Ther. 2008 Jun;325(3):902-9. doi: 10.1124/jpet.107.135343. Epub 2008 Feb 27. J Pharmacol Exp Ther. 2008. PMID: 18305012 Free article.

2

Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization.

Fox GB, Pan JB, Radek RJ, Lewis AM, Bitner RS, Esbenshade TA, Faghih R, Bennani YL, Williams M, Yao BB, Decker MW, Hancock AA. Fox GB, et al. J Pharmacol Exp Ther. 2003 Jun;305(3):897-908. doi: 10.1124/jpet.102.047241. Epub 2003 Feb 20. J Pharmacol Exp Ther. 2003. PMID: 12606600

3

Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.

Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA. Esbenshade TA, et al. J Pharmacol Exp Ther. 2003 Jun;305(3):887-96. doi: 10.1124/jpet.102.047183. Epub 2003 Feb 20. J Pharmacol Exp Ther. 2003. PMID: 12606603

4

The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.

Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, Bozyczko-Coyne D, Spiegel K, Ohtsu H, Williams M, Lin JS. Parmentier R, et al. Biochem Pharmacol. 2007 Apr 15;73(8):1157-71. doi: 10.1016/j.bcp.2007.01.002. Epub 2007 Jan 7. Biochem Pharmacol. 2007. PMID: 17288995

5

Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.

Dvorak CA, Apodaca R, Xiao W, Jablonowski JA, Bonaventure P, Dugovic C, Shelton J, Lord B, Miller K, Dvorak LK, Lovenberg TW, Carruthers NI. Dvorak CA, et al. Eur J Med Chem. 2009 Oct;44(10):4098-106. doi: 10.1016/j.ejmech.2009.04.049. Epub 2009 May 13. Eur J Med Chem. 2009. PMID: 19524331

6

Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease.

Brioni JD, Esbenshade TA, Garrison TR, Bitner SR, Cowart MD. Brioni JD, et al. J Pharmacol Exp Ther. 2011 Jan;336(1):38-46. doi: 10.1124/jpet.110.166876. Epub 2010 Sep 23. J Pharmacol Exp Ther. 2011. PMID: 20864505 Review.

7

Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.

Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA. Fox GB, et al. J Pharmacol Exp Ther. 2005 Apr;313(1):176-90. doi: 10.1124/jpet.104.078402. Epub 2004 Dec 17. J Pharmacol Exp Ther. 2005. PMID: 15608077

8

Detection of low level histamine H3 receptor occupancy by autoradiography.

Le S, Finn JP, Larijani ME, Marino MJ, Schaffhauser H. Le S, et al. J Neurosci Methods. 2009 Dec 15;185(1):70-5. doi: 10.1016/j.jneumeth.2009.09.015. Epub 2009 Sep 16. J Neurosci Methods. 2009. PMID: 19765611

9

3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist.

Hudkins RL, Gruner JA, Raddatz R, Mathiasen JR, Aimone LD, Marino MJ, Bacon ER, Williams M, Ator MA. Hudkins RL, et al. Neuropharmacology. 2016 Jul;106:37-45. doi: 10.1016/j.neuropharm.2015.09.025. Epub 2015 Sep 21. Neuropharmacology. 2016. PMID: 26400408

10

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.

Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J. Ligneau X, et al. J Pharmacol Exp Ther. 1998 Nov;287(2):658-66. J Pharmacol Exp Ther. 1998. PMID: 9808693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

213 results

Results by year